Access
To read this story in full you will need to login or make a payment (see right).
News
Nature 435, 1008-1009 (23 June 2005) | doi:10.1038/4351008a; Published online 22 June 2005
Open Innovation Challenges
-
Novel Approaches to Protecting Maize from Insect Damage
The Seeker is looking for novel approaches to protecting maize from insect damage. This Challenge re...
-
Direct Molecular Detection of Proteins and Nucleic Acids
This Challenge is looking for novel approaches to protein and nucleic acid detection. This is an Id...
- More Challenges
- Powered by:
nature jobs
Research Group Leader
- University of Vienna
- Vienna, Austria
Cardiovascular Electrophysiologist / Pharmacologist - GlaxoSmithKline
- GlaxoSmithKline
- Ware, Harlow - United Kingdom
Drug targeting: is race enough?
Meredith Wadman
Abstract
Pharmaceutical firms urged to look beyond race as first 'Personalized' drug is approved
The expected approval in the United States of the first drug targeted to a specific racial group is sparking debate about the future of 'personalized' medicine.Enthusiasts predict a future in which people are given genetic tests to help choose the drug to which they will respond best.
To read this story in full you will need to login or make a payment (see right).
MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated.
